Association between visceral adipose tissue and major depressive disorder across the lifespan: a Scoping Review

2021 ◽  
Author(s):  
Jia‐In Lee ◽  
Jessica N. Busler ◽  
Caitlin Millet ◽  
Jessica L. Principe ◽  
Leonard L. Levin ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Adipose Tissue ◽  
Depressive Disorder ◽  
Visceral Adipose Tissue ◽  
Scoping Review ◽  
Major Depressive ◽  
Visceral Adipose

Pericardial, intra-abdominal, and subcutaneous adipose tissue in patients with major depressive disorder

2014 ◽  
Vol 130 (2) ◽  
pp. 137-143 ◽  
Author(s):  
K. G. Kahl ◽  
K. Hueper ◽  
U. Schweiger ◽  
M. Gutberlet ◽  
A.-M. Detlef ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Adipose Tissue ◽  
Depressive Disorder ◽  
Subcutaneous Adipose Tissue ◽  
Major Depressive ◽  
Subcutaneous Adipose

scholarly journals Outcome reporting in randomized controlled trials of major depressive disorder treatments in adolescents: a systematic scoping review protocol

2018 ◽  
Author(s):  
Andrea Monsour ◽  
Emma Mew ◽  
Peter Szatmari ◽  
Sagar Patel ◽  
Leena Saeed ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Scoping Review ◽  
Randomized Clinical Trials ◽  
Evidence Synthesis ◽  
Core Outcome Set ◽  
Population Heterogeneity ◽  
Controlled Trials ◽  
Cochrane Central Register ◽  
Major Depressive

Introduction: Major depressive disorder (MDD) is a common mental health condition in adolescents. Randomized clinical trials (RCTs) are the gold-standard for assessing the safety and efficacy of interventions in this population. Heterogeneity in the outcomes measured and reported between RCTs limits the ability to compare, contrast, and combine trial results in a clinically meaningful way. There is currently no core outcome set (COS) available for use in RCTs evaluating interventions in adolescents with MDD. We will conduct a systematic scoping review of outcomes reported in adolescent depression RCTs to assess the variability of trial outcomes and to inform the development of a COS for adolescent MDD. Methods and analysis: We will apply methods based on the Joanna Briggs Institute scoping review methods manual. RCTs evaluating any treatment intervention for adolescent MDD published in the last ten years will be located using an electronic bibliographic database search (MEDLINE, PsycINFO, and Cochrane Central Register of Controlled Trials). Title and abstract screening, full-text screening, and data charting of eligible studies will be performed in duplicate. Outcomes identified will be mapped to an outcome domain framework. Data analysis will include summary statistics of the characteristics of the included trials and outcomes. Ethics and dissemination: The results of this review will inform the development of a COS for adolescent MDD. The development and implementation of a COS for RCTs evaluating interventions in adolescents with MDD promises to help reduce variability in trial outcome selection, definition, measurement, and reporting, ultimately facilitating evidence synthesis that will help to identify best treatment practices for adolescents with MDD. Registration details: This protocol was registered prospectively with the Open Science Framework (https://osf.io/xjz9u/).

Major Depressive Disorder and gut microbiota – Association not causation. A scoping review

2021 ◽  
Vol 106 ◽  
pp. 110111 ◽  
Author(s):  
Igor Łoniewski ◽  
Agata Misera ◽  
Karolina Skonieczna-Żydecka ◽  
Mariusz Kaczmarczyk ◽  
Karolina Kaźmierczak-Siedlecka ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Gut Microbiota ◽  
Depressive Disorder ◽  
Scoping Review ◽  
Major Depressive

Adrenal gland volume, intra-abdominal and pericardial adipose tissue in major depressive disorder

2015 ◽  
Vol 58 ◽  
pp. 1-8 ◽  
Author(s):  
Kai G. Kahl ◽  
Ulrich Schweiger ◽  
Kaweh Pars ◽  
Alicja Kunikowska ◽  
Michael Deuschle ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Adipose Tissue ◽  
Adrenal Gland ◽  
Depressive Disorder ◽  
Major Depressive ◽  
Gland Volume ◽  
Pericardial Adipose Tissue ◽  
Adrenal Gland Volume

scholarly journals Outcomes reported in randomised clinical trials of major depressive disorder treatments in adolescents: a systematic scoping review protocol

BMJ Open ◽  
2019 ◽  
Vol 9 (1) ◽  
pp. e024191 ◽  
Author(s):  
Andrea Monsour ◽  
Emma J Mew ◽  
Peter Szatmari ◽  
Sagar Patel ◽  
Leena Saeed ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Scoping Review ◽  
Evidence Synthesis ◽  
Core Outcome Set ◽  
Population Heterogeneity ◽  
Randomised Clinical Trials ◽  
Cochrane Central Register ◽  
Major Depressive

IntroductionMajor depressive disorder (MDD) is a common mental health condition in adolescents. Randomised clinical trials (RCTs) are the gold standard for assessing the safety and efficacy of interventions in this population. Heterogeneity in the outcomes measured and reported between RCTs limits the ability to compare, contrast, and combine trial results in a clinically meaningful way. There is currently no core outcome set (COS) available for use in RCTs evaluating interventions in adolescents with MDD. We will conduct a systematic scoping review of outcomes reported in adolescent depression RCTs to assess the variability of trial outcomes and to inform the development of a COS for adolescent MDD.Methods and analysisWe will apply methods based on the Joanna Briggs Institute scoping review methods manual. RCTs evaluating any treatment intervention for adolescent MDD published in the last 10 years will be located using an electronic bibliographic database search (MEDLINE, PsycINFO and Cochrane Central Register of Controlled Trials). Title and abstract screening, full-text screening, and data charting of eligible studies will be performed in duplicate. Outcomes identified will be mapped to an outcome-domain framework. Data analysis will include summary statistics of the characteristics of the included trials and outcomes.Ethics and disseminationThe results of this review will inform the development of a COS for adolescent MDD. The development and implementation of a COS for RCTs evaluating interventions in adolescents with MDD promise to help reduce variability in trial outcome selection, definition, measurement and reporting, ultimately facilitating evidence synthesis that will help to identify the best treatment practices for adolescents with MDD.

Sign in / Sign up

Export Citation Format

Share Document